Lisure Science

company

About

Lisure Science is a provider and manufacturer of scientific instruments and equipment in chemical and biological Pharmaceuticals.

  • 251 - 500

Details

Last Funding Type
Angel
Last Funding Money Raised
¥3M
Industries
Biopharma,Biotechnology,Chemical,Manufacturing,Pharmaceutical
Founded date
Dec 22, 2009
Number Of Employee
251 - 500
Operating Status
Active

Founded in Suzhou Industrial Park since 2009, Lisure Science (Suzhou) Co., Ltd is a national hi-tech enterprise. Currently, Lisure has set up with one 20,000㎡production facility (Shengpu) and one 3,000㎡application center (Biobay) . Lisure Science is a professional provider of technology and products in biopharmaceutical separation and purification.

They focus on the development and amplification of separation and purification process, selection and optimization of separation media, customization of separation and purification system, design and implementation of separation and purification projects, providing customer with total solution. In biological production process like filtration and separation, chromatography and purification, on-line buffer mixing, they can also provide automated, intelligent and personalized solution. Their products and services cover the whole biopharmaceutical process from medicine discovery, pilot scale-up to scale production. Now, Lisure provides more than 1000 biopharmaceutical enterprises and R&D institutions with products and services in monoclonal antibody, recombinant protein and bloods products.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
¥33M
Lisure Science has raised a total of ¥33M in funding over 2 rounds. Their latest funding was raised on Dec 14, 2015 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 14, 2015 Series B ¥20M 1 Detail
Sep 24, 2014 Series A ¥10M 1 Detail
Jul 31, 2012 Angel ¥3M 2 Detail

Investors

Number of Lead Investors
Number of Investors
3
Lisure Science is funded by 3 investors. Xinnengliang Touzi and Fudewu Sheng are the most recent investors.
Investor Name Lead Investor Funding Round
Xinnengliang Touzi Series B
Fudewu Sheng Series A
The Linhui Fund Angel